INTECH Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Sell
6,213
-1,186
-16% -$42.7K ﹤0.01% 1789
2026
Q1
$262K Sell
7,399
-34,284
-82% -$1.39M ﹤0.01% 1624
2025
Q4
$1.69M Buy
41,683
+18,487
+80% +$804K 0.02% 824
2025
Q3
$1.09M Buy
23,196
+3,103
+15% +$161K 0.01% 1108
2025
Q2
$1.05M Sell
20,093
-2,412
-11% -$132K 0.01% 1170
2025
Q1
$1.36M Buy
22,505
+5,780
+35% +$373K 0.01% 1008
2024
Q4
$1.14M Buy
16,725
+803
+5% +$56K 0.01% 1047
2024
Q3
$1.15M Buy
15,922
+10,187
+178% +$719K 0.01% 731
2024
Q2
$398K Buy
+5,735
New +$418K ﹤0.01% 882

Other funds holding CNMD

INTECH Investment Management's CNMD Position: Q2 2026 in Review

INTECH Investment Management reduced its CONMED (CNMD) stake by 16% in Q2 2026, selling an estimated $42.7K and leaving 6,213 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

INTECH Investment Management first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.69M in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • INTECH Investment Management held 6,213 shares of CONMED worth $203K as of Q2 2026.
  • INTECH Investment Management sold 1,186 CONMED shares in Q2 2026, an estimated $42.7K.
  • CONMED made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1789 holding.
  • INTECH Investment Management first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's CONMED position peaked at $1.69M in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.